These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24269857)

  • 1. The effects of dopaminergic medication on dynamic decision making in Parkinson's disease.
    Osman M; Ryterska A; Karimi K; Tu L; Obeso I; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2014 Jan; 53():157-64. PubMed ID: 24269857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
    Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?
    Torta DM; Castelli L; Zibetti M; Lopiano L; Geminiani G
    Brain Cogn; 2009 Nov; 71(2):84-91. PubMed ID: 19442427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication.
    Evens R; Hoefler M; Biber K; Lueken U
    Neuropsychologia; 2016 Oct; 91():163-172. PubMed ID: 27475264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease.
    Shohamy D; Myers CE; Grossman S; Sage J; Gluck MA
    Behav Brain Res; 2005 Jan; 156(2):191-9. PubMed ID: 15582105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decomposing effects of dopaminergic medication in Parkinson's disease on probabilistic action selection--learning or performance?
    Smittenaar P; Chase HW; Aarts E; Nusselein B; Bloem BR; Cools R
    Eur J Neurosci; 2012 Apr; 35(7):1144-51. PubMed ID: 22487043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease.
    Michely J; Barbe MT; Hoffstaedter F; Timmermann L; Eickhoff SB; Fink GR; Grefkes C
    Neuropsychologia; 2012 Aug; 50(10):2506-14. PubMed ID: 22776611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude.
    Sharp ME; Viswanathan J; McKeown MJ; Appel-Cresswell S; Stoessl AJ; Barton JJ
    Neuropsychologia; 2013 Nov; 51(13):2679-89. PubMed ID: 23954375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: a neuropsychological and psychophysiological study.
    Euteneuer F; Schaefer F; Stuermer R; Boucsein W; Timmermann L; Barbe MT; Ebersbach G; Otto J; Kessler J; Kalbe E
    Neuropsychologia; 2009 Nov; 47(13):2882-90. PubMed ID: 19545579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa medication improves incidental sequence learning in Parkinson's disease.
    Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
    Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision-making under risk is improved by both dopaminergic medication and subthalamic stimulation in Parkinson's disease.
    Boller JK; Barbe MT; Pauls KA; Reck C; Brand M; Maier F; Fink GR; Timmermann L; Kalbe E
    Exp Neurol; 2014 Apr; 254():70-7. PubMed ID: 24444545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceptual decision-making in patients with Parkinson's disease.
    Djamshidian A; O'Sullivan SS; Lawrence AD; Foltynie T; Aviles-Olmos I; Magdalinou N; Tomassini A; Warner TT; Lees AJ; Averbeck BB
    J Psychopharmacol; 2014 Dec; 28(12):1149-54. PubMed ID: 25237123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
    Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.
    Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM
    Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dopaminergic medications on the time course of explicit motor sequence learning in Parkinson's disease.
    Kwak Y; Müller ML; Bohnen NI; Dayalu P; Seidler RD
    J Neurophysiol; 2010 Feb; 103(2):942-9. PubMed ID: 20018839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease.
    Kwak Y; Müller ML; Bohnen NI; Dayalu P; Seidler RD
    Behav Brain Res; 2012 Apr; 230(1):116-24. PubMed ID: 22343069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Parkinson's disease and dopamine on digit span measures of working memory.
    Grogan JP; Knight LE; Smith L; Irigoras Izagirre N; Howat A; Knight BE; Bickerton A; Isotalus HK; Coulthard EJ
    Psychopharmacology (Berl); 2018 Dec; 235(12):3443-3450. PubMed ID: 30315362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applied strategy in the Iowa Gambling Task: Comparison of individuals with Parkinson's disease to healthy controls.
    Kjær SW; Callesen MB; Larsen L; Borghammer P; Østergaard K; Damholdt MF
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):425-435. PubMed ID: 32283989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The speed of lexical activation is altered in Parkinson's disease.
    Angwin AJ; Chenery HJ; Copland DA; Murdoch BE; Silburn PA
    J Clin Exp Neuropsychol; 2007 Jan; 29(1):73-85. PubMed ID: 17162724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. It's all in the type of the task: Dopamine modulates kinematic patterns during competitive vs. cooperative interaction in Parkinson's disease.
    Straulino E; Scaravilli T; Bulgheroni M; D'Amico E; Castiello U
    Neuropsychologia; 2016 Dec; 93(Pt A):106-115. PubMed ID: 27756693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.